Recurrent Very Late Stent Thrombosis in a Systemic Lupus Erythematous Patient

Coronary artery disease is the most important cause of mortality in patients with systemic lupus erythematous (SLE). After stenting for coronary artery disease in SLE patients similar to non-SLE patients, the risk of stent thrombosis is always present. Although there are reports of stent thrombosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Dong-Yob, Park, Jong-Pil, Ko, Sung-Jun, Lee, Shin-Eun, Jhon, Sung-Hee, Lim, Ji-Hyun, Rhew, Jay-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291722/
https://www.ncbi.nlm.nih.gov/pubmed/22396700
http://dx.doi.org/10.4070/kcj.2012.42.2.118
Descripción
Sumario:Coronary artery disease is the most important cause of mortality in patients with systemic lupus erythematous (SLE). After stenting for coronary artery disease in SLE patients similar to non-SLE patients, the risk of stent thrombosis is always present. Although there are reports of stent thrombosis in SLE patients, very late recurrent stent thrombosis is rare. We experienced a case of very late recurrent stent thrombosis (4 times) in a patient with SLE.

Ejemplares similares